These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 15901483

  • 21. Tiagabine, a GABA uptake inhibitor, attenuates 3-nitropropionic acid-induced alterations in various behavioral and biochemical parameters in rats.
    Dhir A, Akula KK, Kulkarni SK.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr 01; 32(3):835-43. PubMed ID: 18234412
    [Abstract] [Full Text] [Related]

  • 22. Targeting oxidative/nitrergic stress ameliorates motor impairment, and attenuates synaptic mitochondrial dysfunction and lipid peroxidation in two models of Huntington's disease.
    Pérez-De La Cruz V, Elinos-Calderón D, Robledo-Arratia Y, Medina-Campos ON, Pedraza-Chaverrí J, Ali SF, Santamaría A.
    Behav Brain Res; 2009 May 16; 199(2):210-7. PubMed ID: 19100293
    [Abstract] [Full Text] [Related]

  • 23. Neurturin gene therapy improves motor function and prevents death of striatal neurons in a 3-nitropropionic acid rat model of Huntington's disease.
    Ramaswamy S, McBride JL, Herzog CD, Brandon E, Gasmi M, Bartus RT, Kordower JH.
    Neurobiol Dis; 2007 May 16; 26(2):375-84. PubMed ID: 17336076
    [Abstract] [Full Text] [Related]

  • 24. Progressive behavioural changes in the spatial open-field in the quinolinic acid rat model of Huntington's disease.
    Scattoni ML, Valanzano A, Popoli P, Pezzola A, Reggio R, Calamandrei G.
    Behav Brain Res; 2004 Jul 09; 152(2):375-83. PubMed ID: 15196806
    [Abstract] [Full Text] [Related]

  • 25. Striatal modulation of cAMP-response-element-binding protein (CREB) after excitotoxic lesions: implications with neuronal vulnerability in Huntington's disease.
    Giampà C, DeMarch Z, D'Angelo V, Morello M, Martorana A, Sancesario G, Bernardi G, Fusco FR.
    Eur J Neurosci; 2006 Jan 09; 23(1):11-20. PubMed ID: 16420411
    [Abstract] [Full Text] [Related]

  • 26. Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease.
    Diguet E, Fernagut PO, Wei X, Du Y, Rouland R, Gross C, Bezard E, Tison F.
    Eur J Neurosci; 2004 Jun 09; 19(12):3266-76. PubMed ID: 15217383
    [Abstract] [Full Text] [Related]

  • 27. 17 beta-Estradiol may affect vulnerability of striatum in a 3-nitropropionic acid-induced experimental model of Huntington's disease in ovariectomized rats.
    Túnez I, Collado JA, Medina FJ, Peña J, Del C Muñoz M, Jimena I, Franco F, Rueda I, Feijóo M, Muntané J, Montilla P.
    Neurochem Int; 2006 Apr 09; 48(5):367-73. PubMed ID: 16420966
    [Abstract] [Full Text] [Related]

  • 28. Pathological synaptic plasticity in the striatum: implications for Parkinson's disease.
    Picconi B, Pisani A, Barone I, Bonsi P, Centonze D, Bernardi G, Calabresi P.
    Neurotoxicology; 2005 Oct 09; 26(5):779-83. PubMed ID: 15927256
    [Abstract] [Full Text] [Related]

  • 29. Electrophysiological actions of zonisamide on striatal neurons: Selective neuroprotection against complex I mitochondrial dysfunction.
    Costa C, Tozzi A, Luchetti E, Siliquini S, Belcastro V, Tantucci M, Picconi B, Ientile R, Calabresi P, Pisani F.
    Exp Neurol; 2010 Jan 09; 221(1):217-24. PubMed ID: 19913015
    [Abstract] [Full Text] [Related]

  • 30. Participation of par-4 in the degeneration of striatal neurons induced by metabolic compromise with 3-nitropropionic acid.
    Duan W, Guo Z, Mattson MP.
    Exp Neurol; 2000 Sep 09; 165(1):1-11. PubMed ID: 10964480
    [Abstract] [Full Text] [Related]

  • 31. Coexistence of muscarinic long-term depression with electrically induced long-term potentiation and depression at CA3-CA1 synapses.
    McCutchen E, Scheiderer CL, Dobrunz LE, McMahon LL.
    J Neurophysiol; 2006 Dec 09; 96(6):3114-21. PubMed ID: 17005622
    [Abstract] [Full Text] [Related]

  • 32. Neurotrophin-3 restores synaptic plasticity in the striatum of a mouse model of Huntington's disease.
    Gómez-Pineda VG, Torres-Cruz FM, Vivar-Cortés CI, Hernández-Echeagaray E.
    CNS Neurosci Ther; 2018 Apr 09; 24(4):353-363. PubMed ID: 29453932
    [Abstract] [Full Text] [Related]

  • 33. Mitochondrial NAD+-linked State 3 respiration and complex-I activity are compromised in the cerebral cortex of 3-nitropropionic acid-induced rat model of Huntington's disease.
    Pandey M, Varghese M, Sindhu KM, Sreetama S, Navneet AK, Mohanakumar KP, Usha R.
    J Neurochem; 2008 Jan 09; 104(2):420-34. PubMed ID: 17953654
    [Abstract] [Full Text] [Related]

  • 34. Protective role of sertraline against 3-nitropropionic acid-induced cognitive dysfunction and redox ratio in striatum, cortex and hippocampus of rat brain.
    Kumar P, Kumar A.
    Indian J Exp Biol; 2009 Sep 09; 47(9):715-22. PubMed ID: 19957883
    [Abstract] [Full Text] [Related]

  • 35. Induction of heat shock protein 70 reduces the alteration of striatal electrical activity caused by mitochondrial impairment.
    Tantucci M, Mariucci G, Taha E, Spaccatini C, Tozzi A, Luchetti E, Calabresi P, Ambrosini MV.
    Neuroscience; 2009 Oct 20; 163(3):735-40. PubMed ID: 19580850
    [Abstract] [Full Text] [Related]

  • 36. Enhanced long-term synaptic depression in an animal model of depression.
    Holderbach R, Clark K, Moreau JL, Bischofberger J, Normann C.
    Biol Psychiatry; 2007 Jul 01; 62(1):92-100. PubMed ID: 17141742
    [Abstract] [Full Text] [Related]

  • 37. Diabetes mellitus concomitantly facilitates the induction of long-term depression and inhibits that of long-term potentiation in hippocampus.
    Artola A, Kamal A, Ramakers GM, Biessels GJ, Gispen WH.
    Eur J Neurosci; 2005 Jul 01; 22(1):169-78. PubMed ID: 16029206
    [Abstract] [Full Text] [Related]

  • 38. Excitotoxic brain damage involves early peroxynitrite formation in a model of Huntington's disease in rats: protective role of iron porphyrinate 5,10,15,20-tetrakis (4-sulfonatophenyl)porphyrinate iron (III).
    Pérez-De La Cruz V, González-Cortés C, Galván-Arzate S, Medina-Campos ON, Pérez-Severiano F, Ali SF, Pedraza-Chaverrí J, Santamaría A.
    Neuroscience; 2005 Jul 01; 135(2):463-74. PubMed ID: 16111817
    [Abstract] [Full Text] [Related]

  • 39. Pre- and postsynaptic contributions to age-related alterations in corticostriatal synaptic plasticity.
    Akopian G, Walsh JP.
    Synapse; 2006 Sep 01; 60(3):223-38. PubMed ID: 16739119
    [Abstract] [Full Text] [Related]

  • 40. Opposite effects of the A2A receptor agonist CGS21680 in the striatum of Huntington's disease versus wild-type mice.
    Martire A, Calamandrei G, Felici F, Scattoni ML, Lastoria G, Domenici MR, Tebano MT, Popoli P.
    Neurosci Lett; 2007 Apr 24; 417(1):78-83. PubMed ID: 17331645
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.